by in
Entry Author Date Location
BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats 07/24/14 Raleigh Durham
Xconomy Launches in Raleigh-Durham—10th Cluster in Our Network 07/24/14 National
Colorado Company Gets $2.9M Grant to Develop Test for Ebola Virus 06/27/14 Boulder/Denver
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract 12/12/11 Seattle
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Tekmira and AVI Win Ebola Deals, Mirador’s Idea to Prevent Hospital Errors, Tom Ranken’s New Mission, & More Seattle-Area Life Sciences News 07/22/10 Seattle
AVI Biopharma Wins Big Ebola Contract Worth up to $291M 07/16/10 Seattle
Tekmira Nails $140M Defense Contract to Make RNAi Drug for Ebola 07/15/10 Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
AVI Nabs $11.5M Defense Contract 10/05/09 Seattle
AVI Biopharma Settles Into New Digs, Scopes Out Seattle Biotech Talent Pool 09/29/09 Seattle
AVI Nails Down $30M 08/20/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News 08/06/09 Seattle
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent 07/30/09 Seattle
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News 05/07/09 Seattle
Dendreon Drug Prolongs Life, ZymoGenetics Cuts Staff, Microsoft Tackles Biotech & More Seattle-Area Life Sciences News 04/30/09 Seattle
Ebola Fighter AVI Biopharma Gears Up for Biodefense Contracts 04/29/09 Seattle
AVI Gets Patent For Ebola Drug 04/28/09 Seattle
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News 02/05/09 Seattle
AVI Gets Green Light for Ebola Trial 12/24/08 Seattle
AVI Biopharma Out to Reinvent Itself, Making RNA-based Drugs for Ebola and Other Nasty Things 09/10/08 Seattle
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections 08/28/08 Seattle
Alnylam’s Ebola Work Gets $7.5 Million Commitment 08/06/08 Boston
Page 1 of 1